Moderna said Thursday it expects to generate $18.4 billion in sales from its Covid-19 vaccine this year.
In releasing its fourth-quarter earnings, Moderna also said its chief medical officer, Tal Zaks, will leave the company in late September. The company said it has retained Russell Reynolds “to recruit for a new CMO with global and commercial experience.”
Shares of Moderna were up 3.9% in premarket trading.